QQ客服 官方微博 反馈留言

	Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta-analysis
	Tan, Qiaoyun; Liu, Shuxia; Liang, Caixia; Han, Xiaohong; Shi, Yuankai
	2018
卷号	9期号:10页码:1220-1230
关键词	Cancer immune checkpoint inhibitor marker neutrophil to lymphocyte ratio platelet to lymphocyte ratio
ISSN号	1759-7706
DOI	10.1111/1759-7714.12815
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6355679
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Tan, Qiaoyun,Liu, Shuxia,Liang, Caixia,et al. Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta-analysis[J],2018,9(10):1220-1230.
APA	Tan, Qiaoyun,Liu, Shuxia,Liang, Caixia,Han, Xiaohong,&Shi, Yuankai.(2018).Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta-analysis.,9(10),1220-1230.
MLA	Tan, Qiaoyun,et al."Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta-analysis".9.10(2018):1220-1230.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。